Articles by Jill Wechsler - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jill Wechsler

FDA Works to Secure Drug Supply Chain

New policies aim to strengthen inspection and oversight processes.
Sep 2, 2013

New FDA supply chain policies aim to strengthen inspection and oversight processes.

Generic Drugs Face Regulatory and Scientific Challenges

FDA funds research to further development of innovative generics.
Aug 2, 2013

FDA funds research to further development of innovative generics, while working to address review and approval issues.

Regulatory Roundup

Aug 2, 2013

Appropriate use of medications promises to improve patient care and curb spending, prompting pharmacists, public health authorities, and manufacturers to promote multiple adherence strategies.

FDA Urges Greater Focus on Contractor Quality

Outsourcing requires clear policies and written agreements with CMOs.
Jul 2, 2013

Increased manufacturer outsourcing requires clear policies and written agreements with CMOs.

Regulatory Roundup

Compounding, tracking legislation moves forward
Jul 2, 2013

Compounding, tracking legislation moves forward

Congress Considers Legislation to Secure Drug Supply Chain

Bills to regulate drug compounding and establish a national track and trace system face political and policy differences.
Jun 2, 2013

Bills to regulate drug compounding and establish a national track and trace system face political and policy differences.

Regulatory Roundup

An overview of the latest regulatory developments for malaria drugs, biosimilars, and global standards.
Jun 2, 2013

An overview of the latest regulatory developments for malaria drugs, biosimilars, and global standards.

Regulatory Roundup

May 2, 2013

FDA faces budget crunch; Supreme Court hears key cases

Regulatory Convergence Sought for Global Pharma Market

Manufacturers work with international authorities to harmonize drug registration and supply-chain oversight.
May 2, 2013

Manufacturers work with international authorities to harmonize drug registration and supply-chain oversight.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
FindPharma Custom Search
Click here